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Abstract: 
Organochalcogens have been widely studied given their antioxidant activity, which confers 
neuroprotection, antiulcer, and antidiabetic properties. Given the complexity of mammalian 
models, understanding the cellular and molecular effects of organochalcogens has been 
hampered. The nematode worm Caenorhabditis elegans is an alternative experimental model that 
affords easy genetic manipulations, green fluorescent protein tagging, and in vivo live analysis of 
toxicity. We previously showed that manganese (Mn)-exposed worms exhibit oxidative-stress-
induced neurodegeneration and life-span reduction. Here we use Mn-exposed worms as a model 
for an oxidatively challenged organism to investigate the underlying mechanisms of 
organochalcogen antioxidant properties. First, we recapitulate in C. elegans the effects of 
organochalcogens formerly observed in mice, including their antioxidant activity. This is 
followed by studies on the ability of these compounds to afford protection against Mn-induced 
toxicity. Diethyl-2-phenyl-2-tellurophenyl vinyl phosphonate (DPTVP) was the most efficacious 
compound, fully reversing the Mn-induced reduction in survival and life span. Ebselen was also 
effective, reversing the Mn-induced reduction in survival and life span, but to a lesser extent 
compared with DPTVP. DPTVP also lowered Mn-induced increases in oxidant levels, indicating 
that the increased survival associated with exposure to this compound is secondary to a decrease 
in oxidative stress. Furthermore, DPTVP induced nuclear translocation of the transcriptional 
factor DAF-16/FOXO, which regulates stress responsiveness and aging in worms. Our findings 
establish that the organochalcogens DPTVP and ebselen act as antiaging agents in a model of 
Mn-induced toxicity and aging by regulating DAF-16/FOXO signaling and attenuating oxidative 
stress. 
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 Article:
The reactivity of organoselenium and organotellurium compounds [1], [2] and [3], characterized 
by high nucleophilicity and antioxidant potential, provides the basis for their pharmacological 
activities in mammalian models. This class of compounds possesses anti-inflammatory, 
antiulcer, anticancer, and hepato- and neuroprotective properties [1], [4], [5], [6] and [7]. These 
pharmacological properties inherent to ebselen, diphenyl diselenide ((PhSe)2), and diethyl-2-
phenyl-2-tellurophenyl vinyl phosphonate (DPTVP) are attributed to their ability to scavenge 
reactive oxygen species (ROS) and reactive nitrogen species [1], [5], [8] and [9]. It has been also 
shown that toxicity in cancer and neuroblastoma cell lines, caused by high doses of these 
compounds, is modulated by activation of apoptotic pathways [9], [10] and [11]. Nevertheless, 
because of the complexity of mammalian models, it has been difficult to determine the molecular 
pathways and specific proteins that are modulated in response to treatments with these 
compounds. 
 
Accordingly, we used a simpler genetic model, the nematode worm Caenorhabditis elegans. C. 
elegans is a useful experimental model given its high degree of orthology between the worm and 
the human genomes, its ease of handling, and the relatively straightforward generation of 
knockout strains for genes of interest as well as transgenic worms expressing green fluorescent 
protein (GFP)-tagged genetic reporters for tissue expression or protein localization studies [12] 
and [13]. Thanks to the large brood size and short reproductive cycle of C. elegans, low- and 
high-throughput screens for toxicants have been established [14] and [15]. The evaluation of 
several metals in this model has contributed to novel information on their toxic mechanisms. For 
instance, manganese (Mn) toxicity in C. elegans has uncovered the role of dopamine and ROS in 
mediating Mn-induced dopaminergic (DAergic) neurodegeneration [16] and [17]. 
 
Mn-induced neurodegeneration is modulated by activation of several transcription factors. For 
example, Benedetto et al. demonstrated that the expression of SKN-1, the worm's orthologue of 
the human transcription factor nuclear erythroid-derived 2-like 2, is altered by Mn exposure [16]. 
SKN-1 activation, in turn, leads to transcription of antioxidant genes, conferring protection 
against ROS. In parallel, DAF-16, a transcription factor and the worm's orthologue of 
mammalian FOXO (forkhead box O), activates genes that codify antioxidant enzymes, such as 
superoxide dismutase (SOD) and E3 ubiquitin ligase [18]. These antioxidants neutralize reactive 
oxygen species, which are also involved in the aging process. Consequently, this pathway has 
been implicated in the regulation of stress resistance and life span [18] and [19]. Notably, DAF-
16 belongs to the DAF-2 insulin-like cascade, which is negatively regulated by phosphorylation. 
Inhibition of this phosphorylation cascade causes the translocation of DAF-16 into the nucleus, 
where it binds to a DAF-16 binding element (a core sequence TTGTTTAC of the DNA), thus 
increasing transcriptional activation of antioxidants and, in turn, reducing oxidative stress and 
slowing down the aging process [20]. 
 
To address the antioxidant mechanisms of organotellurium and organoselenium, we 
characterized the effects of four organochalcogens (ebselen, (PhSe)2, and diphenyl ditelluride 
((PhTe)2)) and DPTVP (see Fig. 1) on C. elegans survival and life span. We hypothesized that 
these compounds (1) act as antioxidants, decreasing the levels of ROS and carbonylated proteins, 
or (2) attenuate Mn uptake in the worms, thus diminishing its toxic effects. Our results establish 
that DPTVP has the greatest antioxidant activity vs the other tested compounds. The attenuation 
of Mn toxicity by DPTVP is associated with modulation of the DAF-16 pathway, absent changes 
in Mn uptake in the worms. 
Figure 1 has been omitted from this formatted document. 
Materials and methods 
Chemicals 
Ebselen, (PhSe)2, PhTe)2, and DPTVP (Figs. 1A–D) were synthesized according to previously 
described methods [21], [22] and [23]. OxyBlot protein oxidation analysis kits were purchased 
from Millipore (S7150; Billerica, MA, USA). All other reagents were obtained from Sigma (St. 
Louis, MO, USA). 
C. elegans strains and handling of the worms 
C. elegans Bristol N2 (wild type) and TJ356 (DAF-16::GFP) were handled and maintained at 
20 °C onEscherichia coli OP50/NGM (nematode growth medium) plates as previously 
described [24]. All strains were provided by the Caenorhabditis Genetics Center (University of 
Minnesota, Twin Cities, MN, USA). Synchronous L1 populations were obtained by isolating 
embryos from gravid hermaphrodites using bleaching solution (1% NaOCl; 0.25 M NaOH), 
followed by flotation on a sucrose gradient to segregate eggs from dissolved worms and bacterial 
debris, accordingly to standard procedures previously described [25]. All experiments were 
carried out at 22 °C in a humidified-controlled environment. 
Dose–response curves and acute Mn exposure treatments 
The lethal dose 50% (LD50) of organotellurium and organoselenium compounds in C. 
elegans was determined with doses ranging from 0.01 to 5 mM. Five thousand synchronized L1 
worms per dose were treated at 22 °C for 30 min by constant agitation in a rotator with each of 
the compounds, followed by three washes with 85 mM NaCl solution at the end of the 
incubation. Worms were placed on OP50-seeded NGM plates and the dose–response curves 
were plotted from scoring the number of surviving worms on each dish at 24 h postexposure. 
LD50 values were obtained from those curves. We chose doses of organochalcogens below the 
LD05 (5% lethality) for subsequent experiments. To assess the effect of organochalcogens on 
Mn-exposed animals, we pretreated worms for 30 min at 22 °C with nonlethal doses of each of 
the compounds and subsequently washed the worms three times in 85 mM NaCl. The worms 
were then exposed for 30 min at 22 °C to 35 mM manganese chloride (MnCl2), which 
corresponds to the LD25 for MnCl2 as previously reported by Benedetto et al. [16]. Next, the 
worms were washed and placed on OP50-seeded NGM plates. Scoring of surviving worms was 
performed 24 h after MnCl2 exposure. For all dose–response curves, scores were normalized to 
percentage control (0 mM organochalcogens/0 mM MnCl2 exposure). 
Life-span experiments 
Synchronized L1 worms were acutely exposed to the organochalcogen compounds and/or 
MnCl2 as described earlier. Live and healthy-looking worms (around 30 per condition; in 
duplicates) were collected on the same day at the late L4 stage and transferred every 4 days to 
new OP50-seeded NGM plates. Survival was assessed each day until all the worms died. All 
tested C. elegans strains were assessed in parallel and each experiment was performed three 
times. Plotted curves represent averages of those three independent experiments. 
ROS measurement 
Synchronized L1 were acutely pretreated for 30 min with ebselen, (PhSe)2, or DPTVP followed 
by 30 min exposure to MnCl2 (0 or 35 mM) as earlier described. Next, the worms were washed 
two additional times in M9 buffer. 2′,7′-Dichlorodihydrofluorescein diacetate (DCF-DA) at a 
final concentration of 1 mM was added for 1 h and the worms were maintained in the dark. The 
worms were then washed four times in M9 buffer. The worms were frozen and thawed twice and 
homogenized by sonication and then centrifuged. The supernatants were transferred to a 96-well 
plate and their fluorescence levels (excitation 485 nm; emission 535 nm) were detected with a 
FLEXstation III (Molecular Devices, Sunnyvale, CA, USA) preheated to 37 °C. The 
fluorescence from each well was measured for 40 min (at 10-min intervals). Fluorescence 
measurements were normalized to time 0 values and rates of increased fluorescence (reflecting 
ROS levels) were expressed as percentage control. The experiments were repeated three times in 
triplicate independent worm preparations [16]. 
Protein oxidation determination 
Twenty-thousand worms were pretreated for 30 min with DPTVP (0, 1, or 10 μM) and then 
exposed for 30 min to MnCl2 (35 mM), as previously described. Next, the worms were 
homogenized by sonication in a lysis buffer containing 85 mM sodium chloride, 1% Triton X-
100, 10 mM Tris buffer (pH 6.8), 1 × protease inhibitor, and 50 mM dithiothreitol. After 
centrifugation (11,000 g for 1 min), the supernatant was isolated and the protein concentration 
was determined with the Bradford method [26]. One-hundred micrograms of proteins was 
derivatized with 2,4-dinitrophenylhydrazine (DNPH), which is converted to 2,4-
dinitrophenylhydrazone (DNP) in the presence of carbonyls from oxidized proteins. The 
carbonyls were detected by Western blotting with a commercial antibody directed against 
derivatized carbonyl groups (anti-2,4-DNP, rabbit IgG) and visualized by horseradish 
peroxidase-conjugated secondary antibody following the manufacturer's instructions (OxyBlot 
analysis kit; Millipore). Purified β-actin (A1978; Sigma) was used as a control and the bands’ 
density was acquired with ImageJ (W.S. Rasband, U.S. National Institutes of Health, Bethesda, 
MD, USA; http://imagej.nih.gov/ij/, 1997–2011). 
Mn content measurement by atomic absorption spectrophotometry 
Triplicates of 10,000 L1 worms per condition were treated with MnCl2 as previously described. 
The samples were washed eight times with NaCl and subsequently dehydrated in a vacuum oven 
at 65 °C for 2 h and further digested in 200 μl ultrapure nitric acid for 24 h in a sand bath 
(60 °C). A 20-μl aliquot was brought to a 1-ml total volume with 2% nitric acid and analyzed 
for Mn content using graphite furnace atomic absorption spectroscopy (Varian AA240; Varian, 
Palo Alto, CA, USA). Bovine liver digested in ultrapure nitric acid was used as internal standard 
for analysis (NBS Standard Reference Material; U.S. Department of Commerce, Washington, 
DC, USA; diluted at 5 μg Mn/L). 
Epifluorescence microscopy 
For each slide, a minimum of 20 worms were mounted on 4% agarose pads in M9 and 
anesthetized with 0.2% tricaine/0.02% tetramisole in M9 medium. Fluorescence was acquired 
with an epifluorescence microscope (Nikon Eclipse 80i; Nikon Corp., Tokyo, Japan) equipped 
with a Lambda LS xenon lamp (Sutter Instrument Co.) and Nikon Plan Fluor 20 × dry and 
Nikon Plan Apo 60 × 1.3 oil objectives. Microscopes were housed in air-conditioned rooms 
(20–22 °C). 
Statistics 
Dose–response lethality curves, longevity curves, and ROS content and OxyBlot analysis were 
generated with GraphPad Prism (GraphPad Software, Inc.). We used a sigmoidal dose–response 
model with a top constraint at 100% to draw the curves and determine the LD50 or the average 
life-span values. Statistical analysis of significance was carried out using one-way analysis of 
variance for the dose–response curves, longevity curves, and ROS content, followed by post hoc 
Bonferroni test when the overall p value was < 0.05. Unpaired two-tailed t test was used to 
assess statistical differences in mean values. In all figures, error bars represent the standard error 
of the mean. 
Results 
Survival rate and life span after organochalcogen exposure 
As shown in Fig. 2, the LD50 for (PhSe)2 and ebselen corresponded to 0.05 and 0.21 mM, 
respectively. Worms showed higher tolerance to organotellurium vs organoselenium compounds, 
with LD50 of 2.69 and ~ 10 mM for (PhTe)2 and DPTVP, respectively. Because of its high 
toxicity in rodent models, (PhTe)2 was used in this study only to obtain the LD50 for comparison 
with DPTVP. Analogous to a previous rodent study, (PhTe)2 was significantly more toxic than 
DPTVP [27]. 
Figure 2 has been omitted from this formatted document. 
As shown in Fig. 3, life span after 48 h exposure to ebselen (Fig. 3A), (PhSe)2 (Fig. 3B), or 
DPTVP (Fig. 3C) treatment, at all tested doses, was indistinguishable from controls, indicating 
that these compounds do not increase worms’ mortality. 
Figure 3 has been omitted from this formatted document. 
Effects of sublethal doses of ebselen and DPTVP on Mn-induced toxicity 
Mn (35 mM) caused ~ 25% decrease in worm survival. Pretreatment with sublethal doses of 
DPTVP (10 μM) protected the worms, increasing the survival rate to levels indistinguishable 
from those of the control group (Fig. 4C, p < 0.05 compared to the Mn-treated group). Ebselen 
(10 μM) also protected against Mn-induced toxicity (Fig. 4A, p < 0.05 compared to the Mn-
treated group). Higher doses of ebselen caused an increase in Mn-induced toxicity, whereas 
higher DPTVP doses did not affect the worms’ survival (data not shown). In contrast, (PhSe)2 
(10 μM) failed to protect against Mn-induced toxicity, causing a significant increase in the 
worms’ mortality (Fig. 4B, p < 0.05). Based on these data, for the next series of assays we chose 
to use the lower Mn doses, which did not cause any toxic effects. 
Figure 4 has been omitted from this formatted document. 
Effects of ebselen, (PhSe)2, and DPTVP on Mn-induced aging 
As previously noted [16], high Mn doses decreased the life span of exposed worms vs controls 
(Fig. 5,p < 0.05). Ebselen, (PhSe)2, or DPTVP pretreatment prolonged the life span in Mn-
exposed worms (Fig. 5,p < 0.05 vs the 35 mM Mn group). 
Figure 5 has been omitted from this formatted document. 
Effects of ebselen and DPTVP on Mn-induced oxidative stress 
Because oxidative stress is associated with aging, next we characterized parameters of oxidative 
stress. ROS levels were determined with the DCF-DA dye, which is oxidized to the DCF 
fluorophore in the presence of free radicals. Mn exposure caused a significant increase in DCF-
DA oxidation from t = 20 min, reflecting the generation of ROS (Fig. 6, p < 0.05). Pretreatment 
with ebselen, (PhSe)2, or DPTVP significantly decreased ROS levels even in the control, Mn-
untreated animals (Fig. 6, p < 0.01), resulting in a per se effect. Because DPTVP showed reduced 
toxic effects vs ebselen and (PhSe)2 (Fig. 2), we further characterized the antioxidant efficacy of 
DPTVP in Mn-exposed animals by determining protein oxidation as a biochemical parameter. In 
Mn-treated worms, carbonyl levels were significantly increased compared to untreated worms 
(Fig. 7, p < 0.05). This increase was abolished by pretreatment of the worms with 1 or 10 μM 
DPTVP (Fig. 7, p < 0.05 vs the 35 mM Mn group). DPTVP alone showed a per se effect, given 
that the DPTVP-alone groups (1 and 10 μM) showed significantly lower carbonyl levels 
compared to the control group (Fig. 7, p < 0.05). 
Figures 6-7 have been omitted from this formatted document. 
Effects of DPTVP on DAF-16 translocation 
Next, to better understand the mechanisms by which DPTVP mediates its antioxidant and 
antiaging mechanisms, we investigated DAF-16::GFP subcellular localization upon DPTVP 
pretreatment. The worm DAF-16 is orthologous to the FOXO transcription factor in humans and 
plays a key role in regulating longevity. As shown in Fig. 8A, DPTVP pretreatment (1 or 10 μ
M) led to DAF-16::GFP translocation from the cytoplasm to the nucleus (diffuse staining 
in Fig. 8A), consistent with the well-defined circular staining observed in treated 
worms [28] (Figs. 8B and C). 
Fig. 8. DPTVP causes nuclear migration of transcriptional factor DAF-16 in C. elegans. (A) 
Control; (B) DPTVP 1 μM; (C) DPTVP 10 μM. 
 
Effects of organotellurium compounds on Mn levels 
To determine whether DPTVP affects Mn levels in wild-type worms, we measured Mn 
concentrations in whole animals. We observed no change in Mn levels upon DPTVP 
pretreatment compared to worms treated with Mn alone, indicating that DPTVP does not affect 
Mn uptake or release (Fig. 9). 
Figure 9 has been omitted from this formatted document. 
Discussion 
In this study, we used the C. elegans model to investigate the antioxidant properties of 
organochalcogens within the context of a known environmental insult, Mn. We established that 
ebselen, and to a greater extent DPTVP, confers protection against Mn-induced aging and 
toxicity. Our results suggest that these effects are due to reduction in oxidative stress associated 
with the nuclear translocation of the transcription factor FOXO/DAF-16. Furthermore, they 
occur in the absence of significant changes in whole worm Mn concentrations. 
 
Oxidative stress is associated with the pathogenesis of several diseases, is a sequela of multiple 
chemical exposures, and is known to modulate longevity in several experimental models [29], 
[30] and [31]. Using mammalian models, researchers have studied the molecular basis of ROS 
generation, its cellular effects, and the efficacy of various antioxidants in mitigating ROS-
induced cellular damage. The potential for organochalcogens to offer efficacious treatment for 
disease models associated with oxidative stress has been of interest to several research groups 
[1], [2], [23], [32], [33] and [34]. The ROS-scavenging activity and glutathione peroxidase 
mimetic property of the organochalcogens probably account for their efficacy in attenuating 
oxidative stress both in vitro and in in vivo rodent models [8], [32], [34], [35] and [36]. Notably, 
ebselen was deemed a promising molecule and it entered clinical trials [37]. Its failure in these 
trials has led to the design and synthesis of novel organoselenium compounds with antioxidant 
properties for the development of potential therapeutic agents [38] and [39]. Among several of 
the newly tested molecules, DPTVP has been characterized as the most potent antioxidant, as 
well as a hepato- and neuroprotective compound [4], [27], [40] and [41]. 
 
Previous studies have indicated that mice and rats show distinct responses to organochalcogens, 
with rats appearing more sensitive to organotellurium compounds [1]. Notably, diphenyl 
ditelluride afforded protection in adult mice (but not rats) against 4-aminopyridine-induced 
neurotoxicity and oxidative stress [42]. Our studies suggest that, analogous to mice, C. elegans 
exhibited relatively low sensitivity to the toxic effects of organotellurium compounds (Fig. 1). 
Furthermore, diphenyl diselenide was more toxic to C. elegans than its tellurium analogue. The 
rationale for the differential species sensitivity to diphenyl diselenide has yet to be determined; 
however, differences in the rates of metabolism and formation of toxic metabolites probably 
underlie this differential sensitivity [1]. 
 
In worms surviving the acute high-dose exposure to ebselen and (PhSe)2, the toxic effects were 
short-lasting (Figs. 3A and B), with life span in treated and untreated worms revealing no 
significant differences, even when ebselen and (PhSe)2 were applied at doses as high as 100 μM. 
The same trend was also observed for the DPTVP curve (Fig. 3C). Given these observations and 
the lack of chronic sequelae, we opted to study the efficacy of these compounds in attenuating 
Mn-induced toxicity in C. elegans. 
 
Mn is an essential metal and important for brain development and the functioning of multiple 
enzymes, such as Mn-SOD and glutamine synthase [43] and [44]. Nevertheless, exposure to high 
levels of this metal leads to its preferential accumulation in basal ganglia [43] and [44], resulting 
in parkinsonian-like symptoms [44]. Mn can oxidize dopamine and lead to mitochondrial 
dysfunction, causing excessive ROS generation [45]. Accordingly, oxidative stress is one of the 
main features of Mn-induced toxicity. The C. elegans model replicates features inherent to 
mammalian Mn exposure [16], [17] and [46], including specificity to DAergic neurons and 
increased generation of oxidative stress, as well as reduced life span and morphological 
alterations in dopamine-containing neurons [16], [17], [46] and [47]. 
 
In this study, treatment with DPTVP or ebselen failed to extend the worms’ longevity per se, 
although both protected against Mn-induced decrease in life span (Fig. 5). This finding is in 
agreement with Zhang et al. [48], who demonstrated that the antioxidant epigallocatechin gallate 
failed to alter life span in N2 (wild-type) worms under normal conditions (20 °C), yet increased 
the redox potential and survival rate in response to environmental stress [48]. Notably, DPTVP 
and ebselen also decreased the Mn-induced mortality (observed after 24 h exposure, Fig. 4), 
providing additional evidence for the ability of these compounds to confer protection against 
Mn-induced toxicity. 
 
DPTVP and ebselen afford this protection by decreasing oxidative stress in response to Mn 
exposure. ROS generation, assayed by means of DCF-DA dye fluorescence, was significantly 
decreased when worms were pretreated with these compounds, in the presence or in the absence 
of Mn (Fig. 6). In agreement, protein oxidation levels were restored to control levels in worms 
treated with DPTVP (Fig. 7). This reduction in protein oxidation levels and in ROS production 
suggests that DPTVP may act as a scavenging agent, as other antioxidants do in worms [48] and 
[49]. 
 
In addition, DPTVP may also act by modulating intracellular processes that modulate antioxidant 
defenses. Accordingly, we further investigated whether DPTVP caused the translocation of the 
transcription factor DAF-16 into the nucleus. DAF-16 is the worm homologue of human FOXO 
belonging to the insulin/IGF-like signaling pathway, in which it is the central determinant of the 
endocrine control of stress response, aging, fat metabolism, fertility, and diapause [18] and [50]. 
Upstream of DAF-16 is the surface receptor DAF-2; its activity (upon ligand binding) triggers a 
phosphorylation cascade. AKT is downstream of DAF-2 and when phosphorylated, AKT, in 
turn, phosphorylates DAF-16, preventing its nuclear translocation. When the DAF-2 receptor is 
inactivated or deleted, DAF-16 remains nonphosphorylated and therefore translocates into the 
nucleus, where it activates the transcription of prolongevity genes [18] and [50]. In addition, 
other pathways interfere with proteins upstream of DAF-16, thus affecting the translocation of 
this transcription factor [51]. Herein, we demonstrated for the first time that an organotellurium 
compound caused DAF-16 translocation from the cytosol to the nucleus. This finding indicates 
that organotellurium can modulate this pathway, probably by inducing the production of 
enzymatic antioxidants that are dependent upon DAF-16, such as SOD and glutathione 
peroxidase [18]. In turn, these antioxidants can neutralize ROS generated in response to Mn, thus 
attenuating protein oxidation. 
 
A previous study in rats exposed to Mn for 4 months and thereafter cotreated with DPTVP for 2 
weeks revealed a decrease in Mn levels in the striatum of these animals compared with controls 
[4]. Analogous to the present findings in C. elegans, there was decreased oxidative stress in rats 
treated with DPTVP. Accordingly, we investigated whether Mn levels would be decreased in 
worms in response to DPTVP pretreatment. The results showed no change upon such treatment, 
with levels indistinguishable from those in Mn-treated wild-type worms. Accordingly, tellurium, 
the metal inherent to DPTVP, does not seem to compete with Mn for the same transporters (Fig. 
9). In fact, Wetli et al. demonstrated that ebselen decreased iron uptake in HEK293 cells; 
however, this decrease was not mediated through DMT1, which also transports Mn [52]. Thus, 
that study and ours indicate that uptake of Se and Te ions is not mediated via DMT1. 
 
Taken together, our results show that in addition to a direct antioxidant effect [4] and [41], 
pretreatment with DPTVP caused DAF-16 nuclear translocation, protecting the worms from Mn-
induced oxidative stress. Because aging is modulated by oxidative stress and the DAF-16 
pathway [50], we posit that DPTVP possesses antioxidant and antiaging properties, thus 
modulating the insulin/IGF-like signaling in C. elegans. Our findings illustrate the utility of the 
worm model in elucidating protective and toxic mechanisms as well as for the identification of 
pharmacological targets for antioxidant drug development. Future studies could be profitably 
directed at identifying additional targets for the organochalcogens and potential pathways that 
reduce oxidative damage and delay the aging process. 
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